417 related articles for article (PubMed ID: 32878319)
1. Secretome Proteomic Approaches for Biomarker Discovery: An Update on Colorectal Cancer.
Cevenini A; Orrù S; Imperlini E
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32878319
[TBL] [Abstract][Full Text] [Related]
2. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
[TBL] [Abstract][Full Text] [Related]
4. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
5. In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.
Karagiannis GS; Pavlou MP; Saraon P; Musrap N; Xie A; Batruch I; Prassas I; Dimitromanolakis A; Petraki C; Diamandis EP
J Proteomics; 2014 May; 103():121-36. PubMed ID: 24681409
[TBL] [Abstract][Full Text] [Related]
6. Proteomics for discovery of candidate colorectal cancer biomarkers.
Alvarez-Chaver P; Otero-Estévez O; Páez de la Cadena M; Rodríguez-Berrocal FJ; Martínez-Zorzano VS
World J Gastroenterol; 2014 Apr; 20(14):3804-24. PubMed ID: 24744574
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
8. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
[TBL] [Abstract][Full Text] [Related]
9. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS.
Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J
Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638
[TBL] [Abstract][Full Text] [Related]
10. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
[TBL] [Abstract][Full Text] [Related]
11. Next Generation Proteomics for Clinical Biomarker Detection Using SWATH-MS.
Lin Q; Tan HT; Chung MCM
Methods Mol Biol; 2019; 1977():3-15. PubMed ID: 30980318
[TBL] [Abstract][Full Text] [Related]
12. Quantitative mass spectrometry for colorectal cancer proteomics.
Martínez-Aguilar J; Chik J; Nicholson J; Semaan C; McKay MJ; Molloy MP
Proteomics Clin Appl; 2013 Jan; 7(1-2):42-54. PubMed ID: 23027722
[TBL] [Abstract][Full Text] [Related]
13. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment.
Zeng X; Yang P; Chen B; Jin X; Liu Y; Zhao X; Liang S
J Proteomics; 2013 Aug; 89():51-70. PubMed ID: 23748022
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
[TBL] [Abstract][Full Text] [Related]
15. Proteomics strategies for target identification and biomarker discovery in cancer.
Rajcevic U; Niclou SP; Jimenez CR
Front Biosci (Landmark Ed); 2009 Jan; 14(9):3292-303. PubMed ID: 19273274
[TBL] [Abstract][Full Text] [Related]
16. Proteomic approaches to decipher cancer cell secretome.
Brandi J; Manfredi M; Speziali G; Gosetti F; Marengo E; Cecconi D
Semin Cell Dev Biol; 2018 Jun; 78():93-101. PubMed ID: 28684183
[TBL] [Abstract][Full Text] [Related]
17. Secretome Profiling and Computational Biology of Human Leiomyoma Samples Unravel Molecular Signatures with Potential for Diagnostic and Therapeutic Interventions.
Sahar T; Nigam A; Anjum S; Gupta N; Wajid S
Reprod Sci; 2021 Sep; 28(9):2672-2684. PubMed ID: 33905083
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
19. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
Piersma SR; Fiedler U; Span S; Lingnau A; Pham TV; Hoffmann S; Kubbutat MH; Jiménez CR
J Proteome Res; 2010 Apr; 9(4):1913-22. PubMed ID: 20085282
[TBL] [Abstract][Full Text] [Related]
20. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
